Tailoring Molybdenum Nanomaterials with La(III) for Enhanced Antimicrobial Performance in Biomedical Applications

Nanomaterials are increasingly used to target bacteria as an alternative to antibiotics. Nanotechnology may be particularly advantageous in treating bacterial infections. Nanoparticle–microbe interactions play a significant role in disease treatment in the form of antimicrobial agents. The inhibition of cell growth by nanomaterials occurs as a result of the release of metal ions that interact with cellular components through a variety of pathways, including the generation of reactive oxygen species (ROS), pore formation in cell membranes, cell wall damage, DNA damage, and cell cycle arrest. The study of therapeutic treatments for plant diseases and actions to prevent the spread of phytopathogens are causing a growth in nanomaterials therapeutics, which is causing an increase in the use of nanostructured materials. Hence, with this background, the present work focuses thoroughly on synthesis and characterization of La/Mo/SiO ₂ nanomaterials and responses of prepared nanomaterials against different bacteria and fungi.